Litcius/Paper detail

Preclinical Evidence for the Glucocorticoid-Sparing Potential of a Dual Toll-Like Receptor 7/8 Inhibitor in Autoimmune Diseases

Ankita Deshmukh, Albertina Pereira, Nicholas Geraci, Evgeni P. Tzvetkov, Melinda Przetak, Michelle D. Catalina, Eric F. Morand, Andrew T. Bender, Bharat Vaidyanathan

2023Journal of Pharmacology and Experimental Therapeutics18 citationsDOIOpen Access PDF

Topics & Concepts

TLR7Systemic lupus erythematosusImmunologyToll-like receptorReceptorMyeloidTLR9Lupus erythematosusMedicineBiologyInternal medicineInnate immune systemImmune systemGene expressionGeneAntibodyBiochemistryDiseaseDNA methylationImmune Response and InflammationImmune Cell Function and InteractionSystemic Lupus Erythematosus Research
Preclinical Evidence for the Glucocorticoid-Sparing Potential of a Dual Toll-Like Receptor 7/8 Inhibitor in Autoimmune Diseases | Litcius